Why CRISPR babies are still too risky - embryo studies highlight challenges.
Nature, 615(7953): 568-569 PMID 36914863 DOI 10.1038/d41586-023-00756-0
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.